How do I buy Puma Biotechnology (PBYI) stock?

You can purchase shares of Puma Biotechnology (NASDAQ:PBYI) through any online brokerage.View our list of the best stock brokerages

Who are Puma Biotechnology (PBYI) competitors?

Other companies in Puma Biotechnology’s space includes: Tectonic Therapeutic Inc (NASDAQ:TECX), Burning Rock Biotech Ltd (NASDAQ:BNR), Immuneering Corp (NASDAQ:IMRX), PepGen Inc (NASDAQ:PEPG) and AC Immune SA (NASDAQ:ACIU).

What is the forecast, or price target, for Puma Biotechnology (PBYI) stock?

Puma Biotechnology has a consensus price target of $7.00.

What is the current price for Puma Biotechnology (PBYI)?

The stock price for Puma Biotechnology (NASDAQ: PBYI) is $7 last updated January 22, 2026 at 9:27 AM EST.

Does Puma Biotechnology (PBYI) pay a dividend?

There are no upcoming dividends for Puma Biotechnology.

When is Puma Biotechnology (NASDAQ:PBYI) reporting earnings?

Puma Biotechnology does not have any upcoming earnings scheduled.

Is Puma Biotechnology (PBYI) going to split?

There is no upcoming split for Puma Biotechnology.

What sector and industry does Puma Biotechnology (PBYI) operate in?

Puma Biotechnology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Puma Biotechnology (PBYI) Stock Price, Quote, News & History

Bulls vs Bears

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Name

Revenue

Change

Gross

Change

EBITDA

Change

EBIT

Change

Earnings

Change

About

Sector

Health Care

Industry

Biotechnology

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for t...

Comments